Funding, News and Announcements
» Go to news mainCDRD and MS Society of Canada seek research projects
The Centre for Drug Research and Development (CDRD) and the Multiple Sclerosis Society of Canada (MSSC) are continuing their partnership aimed at accelerating preclinical development of novel therapies for Multiple Sclerosis (MS). To achieve this goal, the organizations are from investigators who are working on research projects aimed at developing new disease-modifying therapies for progressive MS. Such therapies may include novel approaches to promote remyelination, repair existing damage and/or protecting neurons to positively impact the progressive forms of the disease.
Recent News
- Social Sciences and Humanities Research Council
- NS‑USA Subsea Cable Socioeconomic Study
- Genome Canada
- The Association of Commonwealth Universities (ACU) Funding Opportunities 2024‑25
- Global Research Fund
- CIHR Institute of Cancer Research
- Atlantic Policy Congress of First Nations Chiefs Secretariat
- Webinar in Equity, Diversity and Inclusion (EDI)